Coeptis Therapeutics Holdings, Inc. (Nasdaq; COEP) ("Coeptis" or the "Company"), a biopharmaceutical and technology company focused on developing innovative ...

Azitra Inc., a Branford-based biopharmaceutical firm, said Thursday it has entered into a share purchase agreement with New York-based institutional investor Alumni Capital LP  that it expects will ...

The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid to focus resources on a pair of cancer cell therapies.

CHICAGO — Grove Biopharma has leased space for its headquarters and research and development (R&D) lab at 400 North Aberdeen ...

Shares of Gilead Sciences, Inc. (GILD) traded nearly 3% lower in pre-market on Friday after the company reported ...

Germany's Merck is on the verge of a billion-euro takeover of US biopharmaceutical company Springworks Therapeutics, with the ...

A global biopharma is fighting malaria in endemic countries through partnerships that harness R&D, broaden access to ...

A conference call will be held today, April 25, 2025, at 16:00 CEST (15:00 BST / 10:00 EDT / 07:00 PDT) to review the ...

The US Food and Drug Administration on Wednesday approved a cancer drug developed by China-based Akeso Inc, marking a ...

Unfortunately, the same cannot be said for Europe. While it has been home to some of the most important biopharmaceutical companies in the world – many of which have consistently delivered ...

Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for ...

Germany’s Merck KGaA (MKGAY), which had confirmed in February it was in advanced talks to buy SpringWorks Therapeutics (SWTX), is nearing a ...